All Publications
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule
Gallagher KE, Kelly H, Cocks N, Dixon S, Mounier-Jack S, Howard N, Watson-Jones D.
Papillomavirus Res 2018;6:33-40.
PMID:30352297
PMCID:PMC6218645
- Published in 2018, Publication
The validity of an area-based method to estimate the size of hard-to-reach populations using satellite images
Nash S, Tittle V, Abaasa A, Sanya R, Hansen C, Grosskurth H, Kapiga S, Grundy C on behalf of the Lake Victoria Consortium for Health Research.
Emerg Themes Epidemiol 2018;15:11.
PMID:30123310
PMCID:PMC6090724
- Published in 2018, Publication
Evaluating the impact of an intervention to increase uptake of modern contraceptives among adolescent girls
Atchison CJ, Mulhern E, Kapiga S, Nsanya MK, Crawford EE, Mussa M, Bottomley C, Hargreaves JR, Doyle AM. BMJ Open 2018;8:e021834.
PMID:29858422
PMCID:PMC5988138
- Published in 2018, Publication
A cluster randomized controlled trial to assess the impact on intimate partner violence
Harvey S, Lees S, Mshana G, Pilger D, Hansen C, Kapiga S, Watts C. BMC Womens Health 2018;18: 55.
PMID:29609568
PMCID:PMC5879641
- Published in 2018, Publication
Increasing voluntary medical male circumcision uptake among adult men in Tanzania.
Increasing voluntary medical male circumcision uptake among adult men in Tanzania.
Wambura M, Mahler H, Grund JM, Larke N, Mshana G, Kuringe E, Plotkin M, Lija G, Makohka M, Hellar A, Terris-Prestholt F, The VMMC – Tanzania Study Group, Hayes RJ, Changalucha J, Weiss HA.
AIDS 2017; 31: 1025-1034.
PMID:28350578
PMCID:PMC5378002
- Published in 2017, Publication
What works for human papillomavirus vaccine introduction in low and middle-income countries?
What works for human papillomavirus vaccine introduction in low and middle-income countries?
Howard N, Gallagher KE, Mounier-Jack S, Burchett HE, Griffiths UK, Kabakama S, LaMontagne DS, Watson-Jones D.
Papillomavirus Res 2017;4:22-5.
PMID:29179865
PMCID:PMC5710981
- Published in 2017, Publication
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.
Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, Burchett HED, LaMontagne DS, Watson-Jones D.
PMID:28575074
PMCID:PMC5456063
- Published in 2017, Publication
Why has global HPV vaccine uptake lagged? A contextual reframing of vaccine introduction.
Why has global HPV vaccine uptake lagged? A contextual reframing of vaccine introduction.
LaMontagne DS, Gallagher KE, Watson-Jones D.
HPV World 2017; Year 1: 10-12.
- Published in 2017, Publication
A cross-sectional analysis of Trichomonas vaginalis infection among heterosexual HIV-1 serodiscordant African couples.
Bochner AF, Baeten JM, Rustagi AS, Nakku-Joloba E, Lingappa JR, Mugo NR, Bukusi EA, Kapiga S, Delany-Moretlwe S, Celum C, Barnabas RV; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.
Sex Transm Infect 2017;93:520-9.
PMID:28377421
- Published in 2017, Publication
Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries between 2007-2016.
Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, Watson-Jones D.
Papillomavirus Res 2017;4:72-8.
PMID:29179873
PMCID:PMC5710977
- Published in 2017, Publication
